Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.1 USD | +1.18% | -0.25% | +18.24% |
May. 02 | Merck: encouraging results in gastric cancer | CF |
May. 01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.